Effect of TNF-α on Raji cells at different cellular levels estimated by various methods

被引:49
作者
Jurisic, V
Bogdanovic, G
Kojic, V
Jakimov, D
Srdic, T
机构
[1] Univ Kragujevac, Sch Med, Kragujevac 34000, Serbia Monteneg
[2] Inst Oncol, Sremska Kamenica, Serbia Monteneg
关键词
apoptosis; cytotoxicity; DNA synthesis; flow cytometry; LDH; necrosis; Raji cell line; SRB assay; TNF-alpha; TNF receptors; total protein mass; H-3]thymidine incorporation;
D O I
10.1007/s00277-005-0010-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor necrosis factor (TNF)-alpha, a pleiotropic cytokine, has been shown to induce diverse and opposite effects on lymphoid malignancy depending on TNF receptor system expression. Based on this, we investigated its in vitro dose- and time-related effect on the malignant B-cell line Raji, derived from Burkitt lymphoma patients, at different intracellular levels. The membrane alteration was estimated by lactate dehydrogenase (LDH) release and by flow cytometry; intracellular metabolic energy by determination of the total intracellular LDH activity; total cytosole protein mass by sulforhodamine B assay; and cell growth by incorporation of [H-3]thymidine into DNA. Significant increase of LDH through cell membrane alteration was accompanied by decrease of intracellular metabolized energy and total protein mass. TNF-alpha at lower concentrations (125 and 250 pg/ml) significantly induced cell proliferation in comparison with 1,000 pg/ml of TNF-alpha, which induced more cell death. TNF-alpha induced maximal apoptosis rate up to 30% after 24 h, showing more effects for a necrotic form of cell death. Here we reported opposite and diverse effects of TNF-alpha at different intracellular levels in Raji cells, when applied in different assays, showing characteristics for every cellular compartment.
引用
收藏
页码:86 / 94
页数:9
相关论文
共 62 条
[11]   Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30:: a role for TNF-R1 activation by endogenous membrane-anchored TNF [J].
Grell, M ;
Zimmermann, G ;
Gottfried, E ;
Chen, CM ;
Grünwald, U ;
Huang, DCS ;
Lee, YHW ;
Dürkop, H ;
Engelmann, H ;
Scheurich, P ;
Wajant, H ;
Strasser, A .
EMBO JOURNAL, 1999, 18 (11) :3034-3043
[12]   Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily [J].
Gruss, HJ .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1996, 26 (03) :143-159
[13]  
HARANAKA K, 1981, JPN J EXP MED, V51, P191
[14]   The biochemistry of apoptosis [J].
Hengartner, MO .
NATURE, 2000, 407 (6805) :770-776
[15]   TUMOR-NECROSIS-FACTOR FOR THE TREATMENT OF MALIGNANCIES [J].
HIEBER, U ;
HEIM, ME .
ONCOLOGY, 1994, 51 (02) :142-153
[16]   Membrane permeability - Transporters and channels: From disease to structure and back - Editorial overview [J].
Higgins, CF .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (04) :495-495
[17]   Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-α via TNF receptor 2 and autocrine up-regulation of MCP-1 [J].
Jöhrer, K ;
Janke, K ;
Krugmann, J ;
Fiegl, M ;
Greil, R .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :1901-1910
[18]  
Jurisic V, 2005, NEOPLASMA, V52, P25
[19]   Correlation of sera TNF-α with percentage of bone marrow plasma cells, LDH, β2-microglobulin, and clinical stage in multiple myeloma [J].
Jurisic, V ;
Colovic, M .
MEDICAL ONCOLOGY, 2002, 19 (03) :133-139
[20]   Modulation of TNF-α activity in tumor PC cells using anti-CD45 and anti-CD95 monoclonal antibodies [J].
Jurisic, V ;
Bogdanovic, G ;
Srdic, T ;
Jakimov, D ;
Mrdjanovic, J ;
Baltic, M ;
Baltic, VV .
CANCER LETTERS, 2004, 214 (01) :55-61